Halozyme Therapeutics | HALO - Trade Debtors



Halozyme Therapeutics reported $316.34M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amarin USD 106.73M 15.54M Mar/2025
Amgen USD 8.7B 569M Jun/2025
Baxter International USD 1.65B 84M Mar/2025
Cytokinetics USD 8.41M 6.4M Jun/2025
DBV Technologies USD 15.69M 3.38M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Halozyme Therapeutics USD 316.34M 11.72M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
MannKind USD 27.14M 1.76M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025